Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: A double-blind randomised placebo-controlled study
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jul 10, 2018